(Q28301261)

https://api.crossref.org/works/10.1038/SJ.CDD.4401888

NF-kappaB regulation in the immune system

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401888

TAK1 is a ubiquitin-dependent kinase of MKK and IKK

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401888

Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401888

Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alpha

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401888

Peptide-induced negative selection of thymocytes activates transcription of an NF-kappa B inhibitor

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401888

IkappaB kinase signaling is essential for maintenance of mature B cells

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401888

NF-kB inhibitor blocks B cell development at two checkpoints

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401888

Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401888

Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401888

Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401888

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.CDD.4401888

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

IKK-beta links inflammation to obesity-induced insulin resistance

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: transgenics and knockouts

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

GMCSF activates NF-kappaB via direct interaction of the GMCSF receptor with IkappaB kinase beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

IkappaB kinase-dependent chronic activation of NF-kappaB is necessary for p21(WAF1/Cip1) inhibition of differentiation-induced apoptosis of monocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis--CREB and NF-kappaB as key regulators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Enhanced NF-kappaB activation and cellular function in macrophages lacking IkappaB kinase 1 (IKK1).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

The transcriptional program of terminal granulocytic differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

NF-κB Activation Is a Critical Regulator of Human Granulocyte Apoptosisin Vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Inhibition of NF-kappaB by a TAT-NEMO-binding domain peptide accelerates constitutive apoptosis and abrogates LPS-delayed neutrophil apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Mouse models of abnormal skeletal development and homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

NF-(kappa)B-inducing kinase controls lymphocyte and osteoclast activities in inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

I{kappa}B kinase (IKK){beta}, but not IKK{alpha}, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

The Role of relB in Regulating the Adaptive Immune Response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

RelB regulates human dendritic cell subset development by promoting monocyte intermediates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Selective loss of c-Rel compromises dendritic cell activation of T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Dendritic cell development and survival require distinct NF-kappaB subunits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Effective antigen presentation by dendritic cells is NF-kappaB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Ikappa B kinase 2 but not NF-kappa B-inducing kinase is essential for effective DC antigen presentation in the allogeneic mixed lymphocyte reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Selective inhibition of NF-?B in dendritic cells by the NEMO-binding domain peptide blocks maturation and prevents T cell proliferation and polarization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Dendritic cell survival and maturation are regulated by different signaling pathways.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Role of NFkappaB in antigen presentation and development of regulatory T cells elucidated by treatment of dendritic cells with the proteasome inhibitor PSI.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

The combined absence of the transcription factors Rel and RelA leads to multiple hemopoietic cell defects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Control of lymphocyte development by nuclear factor-kappaB.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

I-kappa B kinases alpha and beta have distinct roles in regulating murine T cell function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

NF-kappa B is required for the positive selection of CD8+ thymocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Mature T cells depend on signaling through the IKK complex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

X-linked ectodermal dysplasia and immunodeficiency caused by reversion mosaicism of NEMO reveals a critical role for NEMO in human T-cell development and/or survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Nuclear factor kappa B is required for the development of marginal zone B lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

The combined absence of NF-kappa B1 and c-Rel reveals that overlapping roles for these transcription factors in the B cell lineage are restricted to the activation and function of mature cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Failure of lymphopoiesis after adoptive transfer of NF-kappaB-deficient fetal liver cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

IkappaB kinase alpha is essential for mature B cell development and function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Combined deficiency in I B and I B reveals a critical window of NF- B activity in natural killer cell differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Mechanisms of bone metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Nuclear factor-kappa B in rheumatoid synovium. Localization of p50 and p65

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Direct inhibition of NF-kappa B blocks bone erosion associated with inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Hematopoietic NF- B1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

A20, a regulator of NFκB, maps to an atherosclerosis locus and differs between parental sensitive C57BL/6J and resistant FVB/N strains

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Dendritic cells from nonobese diabetic mice exhibit a defect in NF-kappa B regulation due to a hyperactive I kappa B kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Elevated NF-kappaB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor-kappaB activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Supplementation of N-acetylcysteine inhibits NFkappaB activation and protects against alloxan-induced diabetes in CD-1 mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

The preventive anti-oxidant action of thiazolidinediones: a new therapeutic prospect in diabetes and insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Enforced c-REL deficiency prolongs survival of islet allografts1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Inhibition of NF-kappaB-dependent T cell activation abrogates acute allograft rejection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Transplantation tolerance in NF-kappaB-impaired mice is not due to regulation but is prevented by transgenic expression of Bcl-xL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

In vivo suppressive effect of nuclear factor-kappaB inhibitor on neutrophilic inflammation of grafts after orthotopic liver transplantation in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021

NF-kappaB as a target for the prevention of graft-versus-host disease: comparative efficacy of bortezomib and PS-1145.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401888

7 January 2021